NewAmsterdam Pharma Company N.V. (NAMS)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn more- Previous Close
25.85 - Open
25.65 - Bid 19.66 x 200
- Ask 33.17 x 200
- Day's Range
25.10 - 25.75 - 52 Week Range
23.05 - 42.21 - Volume
636,607 - Avg. Volume
1,072,217 - Market Cap (intraday)
2.969B - Beta (5Y Monthly) 0.09
- PE Ratio (TTM)
-- - EPS (TTM)
-2.16 - Earnings Date (est.) Nov 4, 2026
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
51.65
Recent News
View MorePerformance Overview
Trailing total returns as of 9/4/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
-
Market Cap
-
Enterprise Value
-
Trailing P/E
-
Forward P/E
-
PEG Ratio (5yr expected)
-
Price/Sales (ttm)
-
Price/Book (mrq)
-
Enterprise Value/Revenue
-
Enterprise Value/EBITDA
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.00%
-
Return on Assets (ttm)
-20.10%
-
Return on Equity (ttm)
-36.81%
-
Revenue (ttm)
7.12M
-
Net Income Avi to Common (ttm)
-259.5M
-
Diluted EPS (ttm)
-2.16
Balance Sheet and Cash Flow
-
Total Cash (mrq)
633.85M
-
Total Debt/Equity (mrq)
0.01%
-
Levered Free Cash Flow (ttm)
-45.36M
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
